Previous close | 28.69 |
Open | 28.81 |
Bid | 28.89 x 51100 |
Ask | 27.11 x 25600 |
Day's range | 28.80 - 29.00 |
52-week range | 21.14 - 36.37 |
Volume | |
Avg. volume | 1,962,974 |
Market cap | 42.479B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | 30.72 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.29 (1.00%) |
Ex-dividend date | 07 Feb 2024 |
1y target est | N/A |
Eli Lilly stock popped Wednesday after the company's weight-loss drug significantly reduced nighttime sleep apnea events.
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, RMD, ZBH, PODD and LNTH are well-poised to gain from the favorable factors.
Key Insights Given the large stake in the stock by institutions, ResMed's stock price might be vulnerable to their...